GC Biopharma Corp.(KR:006280)
₩132,000.00+1200.00 (+0.92%)
KR:006280
GC Biopharma Corp. Revenue
₩132,000.00
At close:+1200.00 (+0.92%)
Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Revenue
GC Biopharma Corp. Revenue
GC Biopharma Corp. had a revenue of 421.20B in the quarter ending Jun 30, 2026, with -3.28%. This bring the company's revenue in the last twelve months to 1.96T, Decreased 3.87%. In the fiscal year ending Dec 31, 2025, GC Biopharma Corp. had annual revenue of 1.99T with 18.54% growth.
- Revenue (ttm)
- 1.96T
- Revenue Growth
- -2.99%
- P/S Ratio
- 0.76
- Revenue/Employee
- KRW 846,992,384
- Employees
- 2,351
- Market Cap
- KRW 1.51T
Revenue Chart
GC Biopharma Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.99T | 311.39B | 18.54% |
| Dec 31, 2024 | 1.68T | 53.25B | 3.27% |
| Dec 31, 2023 | 1.63T | -84.67B | -4.95% |
| Dec 31, 2022 | 1.71T | 173.49B | 11.28% |
| Dec 31, 2021 | 1.54T | 33.71B | 2.24% |
| Dec 31, 2020 | 1.50T | 134.41B | 9.81% |
| Dec 31, 2019 | 1.37T | 34.83B | 2.61% |
| Dec 31, 2018 | 1.33T | 46.96B | 3.65% |
| Dec 31, 2017 | 1.29T | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

